MoneyWorks4Me

Parenteral Drugs informs about unaudited financial results

12 Feb 2020 Evaluate

Pursant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Parenteral Drugs has informed that the company has attached Unaudited Financial Results (on both Standalone and Consolidated basis) for the quarter ended 31st December, 2019.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1777.10
Dr. Reddys Labs. 1195.25
Cipla 1331.25
Lupin 2011.20
Zydus Lifesciences 1151.40
View more..